SIRO Clinpharm forms alliance with Korean CRO DreamCIS
Pact will broaden SIRO's reach in Asian Clinical trials sector
Mumbai - India, February 08, 2010 -
SIRO Clinpharm a Contract Research Organization (CRO) with presence in India,
Western & Central Eastern Europe, and US today announced its alliance with DreamCIS Inc. a leading CRO based at Seoul,
DreamCIS has close to a decade's experience in offering clinical research services to pharmaceutical companies, bio venture companies, medical device
manufacturers, and functional food producers. Their services range includes Clinical trial management, Pharmacovigilance, Post Marketing
Surveillance (PMS), Data management, Biostatistics and Quality Assurance services.
SIRO Clinpharm has been in the arena of contract clinical research for more than 14 years now, conducting ICH GCP compliant clinical trials for its
global clientele. Apart from the services that DreamCIS provides SIRO's service list also includes Medical Writing, Clinical Trials Supplies
Management, Feasibility and Patient Planning.
"This pact will help us on one hand to build a strong competitive advantage in the Asia Pac region, while on the other hand it will create a
sustainable value for our existing as well as potential customers" said Ajit Nair, PhD, President, India. He further added that "Our goal is to offer
a wider platform of patient recruitment capabilities from Asia Pac region for our global client base."
"We are one of the leading and fast growing CROs in South Korea. However looking at the increasing number of global clinical trials and the rapid
growth in Asian clinical trials market, we were looking at associating ourselves with a CRO having a global exposure; not only from business vertical
perspective but also from perspective of moving up on the learning curve. I think our mutually beneficial alliance with SIRO is a definite step in this
direction," said Won-Jung Choi, President, DreamCIS Inc.
"Korea is a rapidly growing clinical trials market due to various advantages it offers like preapproved and well equipped clinical trial sites,
trained professionals, and transparent and efficient regulatory processes", said Chetan Tamhankar, PhD, SIRO's Chief Executive Officer. "We are
confident this alliance will be of immense value addition to SIRO and widen our global service capabilities."
SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services,
conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. SIRO is one of
the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel
and in Europe at Germany, Romania, Estonia, Greece, Czech Republic and Spain.
Founded in April, 2000, DreamCIS has ever since been dedicated to providing a full range of clinical services for pharmaceutical companies, bio
venture companies medical device manufacturers and functional food producers in Korea. The company has also undertaken projects for some of the top
global pharmaceutical companies for broad range of therapeutic areas in accordance with ICH GCP guidelines.
For more information please visit – www.dreamcis.com